Abbott Diabetes Care Issues Warning on Faulty Glucose Monitors Linked to Deaths and Injuries
Abbott Diabetes Care has issued a warning regarding faulty glucose readings from some of its devices, which have been linked to seven deaths and hundreds of injuries. The company identified that certain sensors from its FreeStyle Libre 3 and FreeStyle Libre 3 Plus lines may provide incorrect low glucose readings. This issue was discovered through internal testing and affects approximately 3 million sensors, with about half of these already expired or used. Abbott advises customers with affected devices to stop using them immediately and dispose of them. The company is offering replacements at no charge. The faulty readings could lead to incorrect treatment decisions for diabetes patients, such as excessive carbohydrate intake or improper insulin dosing, posing serious health risks. While the deaths occurred outside the U.S., 57 severe injuries were reported within the country. Abbott continues to produce sensors and does not anticipate significant supply disruptions. 
